The repurposing of recently approved US-FDA drugs against Gram-negative bacteria's biofilm-forming proteins
Gram-negative bacteria are a significant source of global illness and acquire antimicrobial resistance more rapidly than Gram-positive bacteria. Approximately 60–80% of bacterial resistances are caused by biofilms. The biofilm-associated common drug-resistant Gram-negative bacteria are Actinobacter...
Збережено в:
| Автори: | , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
Elsevier
2026-01-01
|
| Серія: | In Silico Research in Biomedicine |
| Предмети: | |
| Онлайн доступ: | http://www.sciencedirect.com/science/article/pii/S3050787126000193 |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|